COMBINATION CHEMOTHERAPY OF ARA-C-RESISTANT LEUKEMIA-P388 (P388 ARA-C) WITH INHIBITORS OF PURINE AND PYRIMIDINE BIOSYNTHESIS

被引：0
|
作者：
TRADER, MW [1 ]
SCHABEL, FM [1 ]
LASTER, WR [1 ]
BROCKMAN, RW [1 ]
机构：
[1] SOUTHERN RES INST,BIRMINGHAM,AL 35255
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1983年 / 24卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：265 / 265
页数：1
相关论文
共 50 条
  • [41] CIRCUMVENTION OF DRUG-RESISTANCE OF P388/R CELLS BY THE COMBINATION OF ADRIAMYCIN AND MITOXANTRONE WITH HYPERTHERMIA (42-DEGREES-C)
    JUVEKAR, AS
    CHITNIS, MP
    NEOPLASMA, 1991, 38 (02) : 207 - 211
  • [42] TREATMENT OF REFRACTORY ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) - COMBINATION CHEMOTHERAPY WITH VM26 AND CYTOSINE-ARABINOSIDE (ARA-C)
    RIVERA, G
    AUR, RJ
    VERZOSA, M
    AVERY, T
    PRATT, C
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 285 - 285
  • [43] Efficacy of topoisomerase I and II inhibitors in combination with standard chemotherapeutic agents (Ara-C and daunorubicin) in the management of acute myeloid leukemia (AML).
    Saba, HI
    Sullivan, DM
    Loughran, TP
    Moscinski, LC
    Sullivan, PA
    Morelli, GA
    BLOOD, 2003, 102 (11) : 261B - 261B
  • [44] COMBINATION CHEMOTHERAPY AGAINST L1210 AND P388 LEUKEMIA - MELPHALAN-5-FLUOROURACIL, VINCRISTINE-ADRIAMYCIN, MECHLORETHAMINE-HYDROXY-UREA, AND METHOTREXATE-MITOMYCIN C
    MABEL, JA
    MERKER, PC
    WODINSKY, I
    GERAN, RI
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 144 - 144
  • [45] In vivo properties of the conjugates of mitomycin C with estradiol benzoate and estradiol: Pharmacokinetics and antitumor characteristics against P388 leukemia and sarcoma 180
    Ishiki, N
    Onishi, H
    Machida, Y
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1998, 21 (11) : 1180 - 1186
  • [46] Cytotoxicity of C2-symmetric platinum(II) bioxazoline complexes in murine leukemia (P388, L1210) models
    Thorsheim, Chelsea L.
    Ranucci, Alexandra E.
    Whitehill, Gregory D.
    Himeistein, Daniel D.
    Schofield, Mark Hi
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [47] VM-26 AND CYTOSINE-ARABINOSIDE (ARA-C) COMBINATION CHEMOTHERAPY FOR INITIAL INDUCTION FAILURES IN CHILDHOOD LYMPHOCYTIC-LEUKEMIA (ALL)
    RIVERA, G
    AUR, RJA
    DAHL, GV
    AVERY, T
    PRATT, C
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 370 - 370
  • [48] Pharmacology of Combination Chemotherapy of Cytosine Arabinoside (Ara-C) and Uracil Arabinoside (Ara-U) or Tetrahydrouridine (THU) against Murine Leukemia L1210/0 in Tumor-Bearing Mice
    Avramis, Vassilios I.
    Powell, William
    CANCER INVESTIGATION, 1987, 5 (04) : 293 - 299
  • [49] CORRELATION BETWEEN POTENCY OF CALMODULIN INHIBITORS AND EFFECTS ON CELLULAR-LEVELS AND CYTO-TOXIC ACTIVITY OF DOXORUBICIN (ADRIAMYCIN) IN RESISTANT P388 MOUSE LEUKEMIA-CELLS
    GANAPATHI, R
    GRABOWSKI, D
    TURINIC, R
    VALENZUELA, R
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (06): : 799 - 806
  • [50] Inhibition of mTORC1/P70S6K pathway by Metformin synergistically sensitizes Acute Myeloid Leukemia to Ara-C
    Yuan, Fang
    Cheng, Cong
    Xiao, Feiyan
    Liu, Hongcai
    Cao, Shan
    Zhou, Gan
    LIFE SCIENCES, 2020, 243
12345